Article
Implications of Highly Penetrant Genetic Variants on Breast Surgery.
Clinical breast cancer - 1 Apr 2024
Davey Matthew G, Tormey Shona
Abstract excerpt
It seems the most probable beneficiaries from the molecular era are those harboring hereditary genetic variants, which are responsible for 5% to 10% of all breast cancer diagnoses. There are several key implications of such variants on clinical practice, from expedited anticipation of primary cancer diagnoses, which can have their risk mitigated by risk reduction surgery, to pragmatism surrounding the management...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
